ArticleTherapeutic advances in chronic disease2022

Risk assessment in systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.

Qian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.